| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Product containing precisely naftidrofuryl oxalate 100 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely nortriptyline hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely oxazepam 15 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely tolmetin sodium 400 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely paracetamol 160 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Furosemide 20 mg and spironolactone 50 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Tramadol hydrochloride 50 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely temozolomide 5 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Tetracycline 100 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Mexiletine hydrochloride 50 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely clodronate disodium 400 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Prazosin hydrochloride 1 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely nicardipine hydrochloride 20 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely tiotixene hydrochloride 1 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely mexiletine hydrochloride 200 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| fluoxetinhydroklorid 50 milligram och olanzapin 6 milligram, oral kapsel | Has unit of presentation | False | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Nicardipine hydrochloride 30 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Ursodeoxycholic acid 300 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely tiotixene hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Temozolomide 20 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely zonisamide 50 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 2 | 
| Product containing precisely trientine hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely trientine hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| cefalexin (som cefalexinmonohydrat) 500 milligram, oral kapsel | Has unit of presentation | False | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| cefalexin (som cefalexinmonohydrat) 500 milligram, oral kapsel | Has presentation strength denominator unit (attribute) | False | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| cefalexin (som cefalexinmonohydrat) 250 milligram, oral kapsel | Has presentation strength denominator unit (attribute) | False | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| cefalexin (som cefalexinmonohydrat) 250 milligram, oral kapsel | Has unit of presentation | False | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely sibutramine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely sibutramine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Sibutramine hydrochloride 15 mg oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Sibutramine hydrochloride 15 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Tetracycline (as tetracycline hydrochloride) 250 mg oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Tetracycline (as tetracycline hydrochloride) 250 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Acebutolol (as acebutolol hydrochloride) 100 mg oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Acebutolol (as acebutolol hydrochloride) 100 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely acebutolol (as acebutolol hydrochloride) 200 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely acebutolol (as acebutolol hydrochloride) 200 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| amoxicillin (som amoxicillintrihydrat) 250 milligram, oral kapsel | Has unit of presentation | False | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| amoxicillin (som amoxicillintrihydrat) 250 milligram, oral kapsel | Has presentation strength denominator unit (attribute) | False | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| amoxicillin (som amoxicillintrihydrat) 500 milligram, oral kapsel | Has unit of presentation | False | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| amoxicillin (som amoxicillintrihydrat) 500 milligram, oral kapsel | Has presentation strength denominator unit (attribute) | False | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely fluvastatin (as fluvastatin sodium) 40 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely fluvastatin (as fluvastatin sodium) 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Indinavir (as indinavir sulfate) 100 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Indinavir (as indinavir sulfate) 100 mg oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| cefadroxil (som cefadroxilmonohydrat) 500 milligram, oral kapsel | Has unit of presentation | False | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| cefadroxil (som cefadroxilmonohydrat) 500 milligram, oral kapsel | Has presentation strength denominator unit (attribute) | False | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely anagrelide (as anagrelide hydrochloride) 500 microgram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely anagrelide (as anagrelide hydrochloride) 500 microgram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| cefaklor (som cefaklormonohydrat) 250 milligram, oral kapsel | Has unit of presentation | False | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| cefaklor (som cefaklormonohydrat) 250 milligram, oral kapsel | Has presentation strength denominator unit (attribute) | False | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely fluvastatin (as fluvastatin sodium) 20 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely fluvastatin (as fluvastatin sodium) 20 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Ketotifen (as ketotifen fumarate) 1 mg oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Ketotifen (as ketotifen fumarate) 1 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| cefaklor (som cefaklormonohydrat) 500 milligram, oral kapsel | Has unit of presentation | False | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| cefaklor (som cefaklormonohydrat) 500 milligram, oral kapsel | Has presentation strength denominator unit (attribute) | False | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Minocycline (as minocycline hydrochloride) 100 mg oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Minocycline (as minocycline hydrochloride) 100 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely tropisetron (as tropisetron hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely tropisetron (as tropisetron hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely minocycline (as minocycline hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely minocycline (as minocycline hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely topotecan (as topotecan hydrochloride) 250 microgram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely topotecan (as topotecan hydrochloride) 250 microgram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Flucloxacillin (as flucloxacillin sodium) 500 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Flucloxacillin (as flucloxacillin sodium) 500 mg oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely loxapine (as loxapine succinate) 10 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely loxapine (as loxapine succinate) 10 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| ampicillin (som ampicillintrihydrat) 250 milligram och floxacillin (som natriumflukloxacillin) 250 milligram, oral kapsel | Has unit of presentation | False | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| ampicillin (som ampicillintrihydrat) 250 milligram och floxacillin (som natriumflukloxacillin) 250 milligram, oral kapsel | Has presentation strength denominator unit (attribute) | False | Capsule (unit of presentation) | Inferred relationship | Some | 2 | 
| ampicillin (som ampicillintrihydrat) 250 milligram och floxacillin (som natriumflukloxacillin) 250 milligram, oral kapsel | Has presentation strength denominator unit (attribute) | False | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Levothyroxine sodium anhydrous 25 microgram oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Levothyroxine sodium anhydrous 25 microgram oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely loxapine (as loxapine succinate) 25 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely loxapine (as loxapine succinate) 25 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely loxapine (as loxapine succinate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely loxapine (as loxapine succinate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Levothyroxine sodium anhydrous 150 microgram oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Levothyroxine sodium anhydrous 150 microgram oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Levothyroxine sodium anhydrous 50 microgram oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Levothyroxine sodium anhydrous 50 microgram oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Flucloxacillin (as flucloxacillin sodium) 250 mg oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Flucloxacillin (as flucloxacillin sodium) 250 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Imatinib (as imatinib mesilate) 400 mg oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Imatinib (as imatinib mesilate) 400 mg oral capsule | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 | 
| Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | True | Capsule (unit of presentation) | Inferred relationship | Some |  | 
| Levothyroxine sodium anhydrous 100 microgram oral capsule | Has presentation strength denominator unit (attribute) | True | Capsule (unit of presentation) | Inferred relationship | Some | 1 |